期刊文献+

声辐射力脉冲成像与APRI指数评价慢性丙型肝炎肝纤维化的临床价值 被引量:19

Clinical value of acoustic radiation force impulse imaging and APRI for quantitative evaluating the degree of liver fibrosis in chronic hepatitis C patients
原文传递
导出
摘要 目的探讨声辐射力脉冲成像(acoustic radiation force impulse,ARFI)技术和天门冬氨酸氨基转移酶与血小板比值指数(AST/PLT ratio index,APRI)无创评价慢性丙型肝炎肝纤维化程度的临床应用价值。方法对107例慢性丙型肝炎患者应用ARFI技术检测肝实时弹性,并计算APRI指数,所有患者均于检测后1周内行肝穿刺活检,以病理检查结果为金标准,比较ARFI测值和APRI指数对慢性丙型肝炎肝纤维化的诊断价值。结果慢性丙型肝炎患者肝纤维化分期为S1~S4期的ARFI分别为(1.26±0.27)m/s、(1.45±0.51)m/s、(2.03±0.54)m/s和(2.29±0.82)m/s,APRI分别为0.30±0.46、0.29±0.21、0.59±0.56和0.63±0.35。ARFI和APRI测值均与肝纤维化分期存在相关,相关系数分别为0.61和0.49(P<0.001)。ARFI和APRI诊断慢性丙型肝炎肝纤维化S≥2的ROC曲线下面积分别为0.779、0.724;S≥3的曲线下面积分别为0.866、0.786;S=4的曲线下面积分别为0.790、0.779。结论ARFI技术较APRI指数能更准确地定量评价慢性丙肝肝纤维化程度,具有良好的临床应用前景。 Objective To investigate the diagnostic value of the acoustic radiation force impulse (ARFI) technology and AST/PLT ratio index (APRI) for the assessment of the liver fibrosis in chronic hepatitis C patients. Methods 107 patients with chronic hepatitis C were included, the subjects were underwent liver biopsy,liver function, blood count, as well as real-time acoustic elastography examination.The APRI was calculated according the following formula, APRI = AST (ULN)/PLT ( 10^9/L). ARFI and APRI were compared by correlation with liver fibrosis stage in chronic hepatitis C. Referring to the histologic fibrosis stage on liver biopsy,all the ARFI and the APRI value were assessed by using ROC curve analysis. The corresponding cut-off values, sensitivity and specificity were also calculated and compared.Results The mean values of ARFI and APRI were (1.26 ± 0.27)m/s and 0.30±0.46 for the patients with S1,(1.45 ±0.51)m/s and 0.29 ± 0.21 for those with S2,(2.03 ± 0.54) m/s and 0.59 ± 0.56 for those with S1,(1.45 ± 0.51)m/s and 0.29 ± 0.21 for those with S2,(2.03 ± 0.54) m/s and 0.59 ± 0.56 for those with S3,(2.29 ± 0.82) m/s and 0.63 ± 0.35 for those with S4,respectively. ARFI ( r = 0.61, P〈0. 001) had a better correlation with liver fibrosis stage in chronic hepatitis C than APRI ( r = 0.49, P 〈0. 001). Cut-off points of ARFI and APRI were 1. 529 m/s and 0. 170 for S≥2,1. 780 m/s and 0. 277 for S≥3,1. 780 m/s and 0. 446 for S = 4, respectively. Accordingly, the areas under the ROC curves for ARFI and APRI were 0. 779 and 0. 724 for S≥2,0. 866 and 0. 786 for S≥3,0. 790 and 0. 779 for S= 4,respectively. Coneluslons As a nondnvasive technology, ARFI is more accurate when applied to evaluate liver fibrosis in patients with chronic hepatitis C than APRI. ARFI technology has potential value for quantitatme evaluation of the liver fibrosis for chronic hepatitis C.
出处 《中华超声影像学杂志》 CSCD 北大核心 2013年第1期30-33,共4页 Chinese Journal of Ultrasonography
基金 首都医学发展科研基金项目(2009-3059)
关键词 超声检查 肝炎 丙型 肝硬化 声辐射力脉冲成像 Ultrasonography Hepatitis C Liver cirrhosis Acoustic radiation force impulse
  • 相关文献

参考文献3

二级参考文献28

  • 1杨志芳,毛飞,黄正明.肝纤维化的形成机制及治疗的研究进展[J].解放军药学学报,2006,22(2):129-132. 被引量:13
  • 2Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, Colombo M. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007; 56:968-973.
  • 3Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, Darriet M, Couzigou P, De Ledinghen V. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128:343-350.
  • 4Chang J, Tan HH, Yew BS. Transient elastography (FibroScan) to assess hepatic fibrosis in Chinese with chronic hepatitis B. 17th Asian Pacific Association for the Study of Liver Conference. 2007.
  • 5Kim KM, Choi WB, Park SH, Yu E, Lee SG, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ. Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors. J Gastroentero12007; 42:382-388.
  • 6Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, de Ledinghen V, Marcellin P, Dhumeaux D, Trinchet JC, Beaugrand M. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41:48-54.
  • 7Roulot D, Czernichow S, Le Clesiau H, Costes JL, Vergnaud AC, Beaugrand M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol 2008; 48:606-613.
  • 8Rifai K, Bahr MJ, Mederacke I, Bantel H, Bayer D, Boozari B, Wedemeyer H, Manns MP, Gebel M. Acoustic Radiation Force Imaging (ARFI) as a new method of Ultrasonographic elastography allows accurate and flexible assessment of liver stiffness. Copenhagen: Poster presentation EASL, 2009.
  • 9Poynard T, Halfon P, Castera L, Charlotte F, Le Bail B, Munteanu M, Messous D, Ratziu V, Benhamou Y, Bourliere M, De Ledinghen V. Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation. Aliment Pharmacol Ther 2007; 25:733-739.
  • 10Poynard T, Halfon P, Castera L, Munteanu M, Imbert-Bismut F, Ratziu V, Benhamou Y, Bourliere M, de Ledinghen V. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem 2007; 53:1615-1622.

共引文献246

同被引文献173

引证文献19

二级引证文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部